Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
暂无分享，去创建一个
V. Seshan | S. Larson | S. Baxi | A. Ho | J. Fagin | R. Ghossein | R. Tuttle | J. Knauf | K. Pentlow | E. Sherman | R. Grewal | M. Sabra | S. Fish | L. Boucai | L. Dunn | S. Haque | V. Tchekmedyian | D. Pfister | Jamie Walters | Laura Boucai